Dr. Clover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 NE Neff Rd
Bend, OR 97701Phone+1 541-706-5800
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2015 - 2018
- Mayo Clinic College of Medicine and Science (Scottsdale)Residency, Internal Medicine, 1999 - 2002
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1999
Certifications & Licensure
- OR State Medical License 2018 - 2025
- WI State Medical License 2015 - 2025
- AK State Medical License 2011 - 2021
- CO State Medical License 2002 - 2011
- AZ State Medical License 2001 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.Ayotola Fatola, Michael D Evans, Jenna Brown, Elizabeth Davis, Andrew Johnson
Blood Advances. 2025-01-28 - 2 citationsA descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun
Blood Advances. 2024-02-13 - 18 citationsRace, rituximab, and relapse in TTP.Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian
Blood. 2022-09-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: